# OnCo record cdk-inhibitors (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/cdk-inhibitors/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "cdk-inhibitors" ;
  schema:name "Cyclin-dependent kinase inhibitors"@en ;
  schema:alternateName "CDK inhibitors"@en, "CDK inhibition"@en, "Cyclin dependent kinase inhibitors"@en ;
  schema:description "These drugs block selected enzymes that control cell division or gene reading. The enzyme, exposure and measured outcome matter; slower growth can mean a pause rather than cell death."@en ;
  schema:url <https://onco.cc/terms/cdk-inhibitors/> ;
  schema:dateModified "2026-11-12"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/23064645/>, <https://www.uniprot.org/uniprotkb/P24941/entry>, <https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib>, <https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samuraciclib>, <https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk9-inhibitor-gfh009>, <https://pubmed.ncbi.nlm.nih.gov/22430491/>, <https://pubmed.ncbi.nlm.nih.gov/38507751/>, <https://pubmed.ncbi.nlm.nih.gov/38224653/>, <https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilaciclib> ;
  onco:related <https://onco.cc/technologies/cdk46-inhibitor/>, <https://onco.cc/targets/cdk4-6/>, <https://onco.cc/targets/cdk2/>, <https://onco.cc/targets/cdk9/>, <https://onco.cc/targets/rb1/>, <https://onco.cc/terms/chemical-probe/>, <https://onco.cc/terms/drug-target-and-mechanism/> .
